Future medical applications of single-cell sequencing in cancer

[1]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[2]  A. Nalla,et al.  Oncogenic role of p53 is suppressed by si-RNA bicistronic construct of uPA, uPAR and cathepsin-B in meningiomas both in vitro and in vivo. , 2011, International journal of oncology.

[3]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[4]  M. Middleton,et al.  Circulating melanoma cells and survival in metastatic melanoma. , 2011, International journal of oncology.

[5]  Schraga Schwartz,et al.  Detection and Removal of Biases in the Analysis of Next-Generation Sequencing Reads , 2011, PloS one.

[6]  Simon Tavaré,et al.  CNAseg - a novel framework for identification of copy number changes in cancer from second-generation sequencing data , 2010, Bioinform..

[7]  M. Jimenez-Linan,et al.  Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer , 2010, British Journal of Cancer.

[8]  M. Nowak,et al.  Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.

[9]  L. Santarpia,et al.  Breast cancer assessment tools and optimizing adjuvant therapy , 2010, Nature Reviews Clinical Oncology.

[10]  J. Tosoian,et al.  PSA and Beyond: The Past, Present, and Future of Investigative Biomarkers for Prostate Cancer , 2010, TheScientificWorldJournal.

[11]  M. Gerlinger,et al.  How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine , 2010, British Journal of Cancer.

[12]  K. Maclennan,et al.  Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens , 2010, Nucleic acids research.

[13]  Nada Jabado,et al.  New technologies for the detection of circulating tumour cells. , 2010, British medical bulletin.

[14]  Thomas J. Hardcastle,et al.  Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma , 2010, Oncogene.

[15]  Catalin C. Barbacioru,et al.  Tracing the Derivation of Embryonic Stem Cells from the Inner Cell Mass by Single-Cell RNA-Seq Analysis , 2010, Cell stem cell.

[16]  Karla Kerlikowske,et al.  Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. , 2010, Journal of the National Cancer Institute.

[17]  Joshua F. McMichael,et al.  Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.

[18]  M. Gönen,et al.  Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. , 2010, The Journal of clinical investigation.

[19]  L. Frati,et al.  HE4: a new potential early biomarker for the recurrence of ovarian cancer , 2010, Tumor Biology.

[20]  A. Børresen-Dale,et al.  COMPLEX LANDSCAPES OF SOMATIC REARRANGEMENT IN HUMAN BREAST CANCER GENOMES , 2009, Nature.

[21]  A. Vincent-Salomon,et al.  Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  Raymond R Tubbs,et al.  Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines. , 2009, Archives of pathology & laboratory medicine.

[23]  Ryan D. Morin,et al.  Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.

[24]  Kenny Q. Ye,et al.  Sensitive and accurate detection of copy number variants using read depth of coverage. , 2009, Genome research.

[25]  J. Kitzman,et al.  Personalized Copy-Number and Segmental Duplication Maps using Next-Generation Sequencing , 2009, Nature Genetics.

[26]  G. Hannon,et al.  DNA Sudoku--harnessing high-throughput sequencing for multiplexed specimen analysis. , 2009, Genome research.

[27]  D. Berry,et al.  I‐SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy , 2009, Clinical pharmacology and therapeutics.

[28]  Michael R. Speicher,et al.  Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays , 2009, Nucleic acids research.

[29]  M. Emmert-Buck,et al.  Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry. , 2009, Journal of proteome research.

[30]  S. Bersani,et al.  Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria. , 2009, American journal of clinical pathology.

[31]  Catalin C. Barbacioru,et al.  mRNA-Seq whole-transcriptome analysis of a single cell , 2009, Nature Methods.

[32]  H. Ohgaki,et al.  Whole genome amplification for array comparative genomic hybridization using DNA extracted from formalin-fixed, paraffin-embedded histological sections. , 2009, The Journal of molecular diagnostics : JMD.

[33]  B. Lakshmi,et al.  Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA). , 2009, Blood.

[34]  S. Turner,et al.  Real-Time DNA Sequencing from Single Polymerase Molecules , 2009, Science.

[35]  Y. Nakatani,et al.  Molecular analysis of multifocal prostate cancer by comparative genomic hybridization , 2008, The Prostate.

[36]  R. Scott,et al.  Whole genome amplification and its impact on CGH array profiles , 2008, BMC Research Notes.

[37]  Carl W. Miller,et al.  ERCC5 is a novel biomarker of ovarian cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  A. Ullrich,et al.  Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. , 2008, Cancer cell.

[39]  G. Kallergi,et al.  Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer , 2008, Clinical Cancer Research.

[40]  R. Reinhardt,et al.  High-resolution array comparative genomic hybridization of single micrometastatic tumor cells , 2008, Nucleic acids research.

[41]  Charles M. Perou,et al.  Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution , 2008, Clinical Cancer Research.

[42]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[43]  A. Vincent-Salomon,et al.  Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues , 2007, Journal of Clinical Pathology.

[44]  S. Tavaré,et al.  High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer , 2007, Genome Biology.

[45]  A. Vincent-Salomon,et al.  Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[46]  J. Andersen,et al.  Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases , 2007, Breast Cancer Research and Treatment.

[47]  R. Beroukhim,et al.  Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.

[48]  E. Small,et al.  Evaluation and significance of circulating epithelial cells in patients with hormone‐refractory prostate cancer , 2007, BJU international.

[49]  S. Nofech-Mozes,et al.  Intratumoral Heterogeneity of HER2/neu in Breast Cancer—A Rare Event , 2007, The breast journal.

[50]  Michael R. Speicher,et al.  High resolution array-CGH analysis of single cells , 2006, Nucleic acids research.

[51]  Kenny Q. Ye,et al.  Novel patterns of genome rearrangement and their association with survival in breast cancer. , 2006, Genome research.

[52]  C. Maley,et al.  Cancer as an evolutionary and ecological process , 2006, Nature Reviews Cancer.

[53]  Igor Jurisica,et al.  Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity , 2006, Clinical Cancer Research.

[54]  D. Mavroudis,et al.  Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  Carissa A. Sanchez,et al.  Genetic clonal diversity predicts progression to esophageal adenocarcinoma , 2006, Nature Genetics.

[56]  K. Zang,et al.  Intratumoral genetic heterogeneity in pilocytic astrocytomas revealed by CGH-analysis of microdissected tumor cells and FISH on tumor tissue sections. , 2006, International journal of oncology.

[57]  M. Perraki,et al.  Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[58]  N. Pandis,et al.  Cytogenetic manifestations of multiple myeloma heterogeneity , 2005, Genes, chromosomes & cancer.

[59]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[60]  J. Squire,et al.  Use of whole genome amplification and comparative genomic hybridisation to detect chromosomal copy number alterations in cell line material and tumour tissue , 2004, Cytogenetic and Genome Research.

[61]  N. Skakkebaek,et al.  Cytogenetic investigation of testicular carcinoma in situ and early seminoma by high-resolution comparative genomic hybridization analysis of subpopulations flow sorted according to DNA content. , 2004, Cancer genetics and cytogenetics.

[62]  Karla Kerlikowske,et al.  Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. , 2003, Journal of the National Cancer Institute.

[63]  Daniel Pinkel,et al.  Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH. , 2003, Genome research.

[64]  S. Kingsmore,et al.  Comprehensive human genome amplification using multiple displacement amplification , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[65]  N. Wolmark,et al.  Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. , 2001, Seminars in oncology.

[66]  W. Gerald,et al.  Genetic heterogeneity and clonal evolution in neuroblastoma , 2001, British Journal of Cancer.

[67]  G. Noël,et al.  [Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853]. , 2001, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[68]  D. Santini,et al.  Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH. , 2001, Cytometry.

[69]  K. Rajewsky,et al.  Single-cell PCR analysis of T helper cells in human lymph node germinal centers. , 2000, The American journal of pathology.

[70]  J. Peterse,et al.  Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853 , 2000, The Lancet.

[71]  H. Höfler,et al.  Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. , 1999, Cancer genetics and cytogenetics.

[72]  M. Speicher,et al.  Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[73]  J. Uhr,et al.  Flowcytometry ‐ Principles and Feasibility in Transfusion Medicine. Enumeration of Epithelial Derived Tumor Cells in Peripheral Blood , 1998 .

[74]  A. Chott,et al.  Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspects. , 1998, British Journal of Cancer.

[75]  R. Jakesz,et al.  Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer , 1998, Breast Cancer Research and Treatment.

[76]  W. Sterry,et al.  Molecular analysis of the immunoglobulin VH gene rearrangement in a primary cutaneous immunoblastic B-cell lymphoma by micromanipulation and single-cell PCR. , 1997, The Journal of investigative dermatology.

[77]  H. G. van der Poel,et al.  Intratumoral nuclear morphologic heterogeneity in prostate cancer. , 1997, Urology.

[78]  J. Andersen,et al.  Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. , 1996, Cancer research.

[79]  F. Mitelman,et al.  Clonal heterogeneity in breast cancer: Karyotypic comparisons of multiple intra—and extra—tumorous samples from 3 patients , 1995, International journal of cancer.

[80]  T C Gasser,et al.  Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer. , 1995, Cytometry.

[81]  C. Marosi,et al.  Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer. , 1995, British Journal of Cancer.

[82]  S. Coons,et al.  Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma. , 1995, Cancer research.

[83]  B. Johansson,et al.  Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups , 1995, Genes, chromosomes & cancer.

[84]  B Fisher,et al.  Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. , 1993, The New England journal of medicine.

[85]  R. Hubert,et al.  Whole genome amplification from a single cell: implications for genetic analysis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[86]  P. Fitzgerald.  Homogeneity and heterogeneity in pancreas cancer: presence of predominant and minor morphological types and implications , 1986, International journal of pancreatology : official journal of the International Association of Pancreatology.

[87]  F. Hirsch,et al.  Tumor heterogeneity in lung cancer based on light microscopic features , 1983, Virchows Archiv A.

[88]  S. Szelinger,et al.  Bar-coded, multiplexed sequencing of targeted DNA regions using the Illumina Genome Analyzer. , 2011, Methods in molecular biology.

[89]  J. Troge,et al.  Inferring tumor progression from genomic heterogeneity. , 2010, Genome research.

[90]  S. Turner,et al.  Real-time DNA sequencing from single polymerase molecules. , 2010, Methods in enzymology.

[91]  Derek Y. Chiang,et al.  High-resolution mapping of copy-number alterations with massively parallel sequencing , 2009, Nature Methods.

[92]  Timothy B. Stockwell,et al.  Mechanism of chimera formation during the Multiple Displacement Amplification reaction , 2007, BMC biotechnology.

[93]  Alan Mackay,et al.  Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisation , 2007, Laboratory Investigation.

[94]  C. Thorns,et al.  Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder , 2004, International Urology and Nephrology.

[95]  David B. Krizman,et al.  The genetics of cancer—a 3D model , 1999, Nature Genetics.

[96]  J. Uhr,et al.  Flow cytometry--principles and feasibility in transfusion medicine. Enumeration of epithelial derived tumor cells in peripheral blood. , 1998, Vox sanguinis.

[97]  C V Jongeneel,et al.  Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones. , 1996, Immunity.

[98]  B J Williams,et al.  Comparative genomic hybridization. , 1996, Methods in molecular medicine.